Both in Pharmaceuticals
Lyell Immunopharma vs Assembly Biosciences
Over the past year LYEL returned −3.3% and ASMB returned −36.8%; their daily moves had a correlation of 0.36.
LYEL −3.3% ASMB −36.8%Growth of $1, one year, split-adjusted
| Metric | LYEL | ASMB |
|---|---|---|
| Price | $15.43 | $19.87 |
| Market cap | $378.1M | $404.6M |
| Today | +43.27% | −0.25% |
| 1 month | +79.2% | −10.4% |
| 6 months | −26.0% | −36.6% |
| Year to date | −49.9% | −41.6% |
| 1 year | −6.8% | −36.3% |
| Revenue growth (YoY) | −50.0% | +38.9% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −1118875.0% | −28.8% |
| P/E (TTM) | — | — |
| Price / sales | 14,004.2× | 5.4× |
| Net cash | $204.1M | $320.4M |
| Dividend yield | — | — |
| Volatility (60d) | 101.1% | 63.6% |
| Short % of float | 15.8% | 28.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).